Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Jun 17.
Published in final edited form as: Synlett. 2013 May 17;24(10):10.1055/s-0033-1338842. doi: 10.1055/s-0033-1338842

SNAr-Derived Decomposition By-products Involving Pentafluorophenyl Triazolium Carbenes

Xiaodan Zhao 1, Garrett S Glover 1, Kevin M Oberg 1, Derek M Dalton 1, Tomislav Rovis 1,
PMCID: PMC3873771  NIHMSID: NIHMS522306  PMID: 24379522

Abstract

Pentafluorophenyl triazolium carbenes, widely used in NHC-catalysis, can decompose by several mechanisms. Under high concentration conditions, the azolium may undergo a pentafluorophenyl exchange by a proposed SNAr mechanism to give an inactive salt. In the presence of appropriate substrates, cyclization on the ortho-position of the arene can occur, also by SNAr. These adducts provide a potential pathway for catalyst decomposition and serve as a caveat to the development of new reactions and catalysts.

Keywords: Pentafluorophenyl N-heterocyclic carbene, inner salt, spirocyclic oxindole, decomposition


N-Heterocyclic carbene (NHC) catalysis is dominated by the triazolium scaffold, with the huge majority of such catalysts bearing at least one aryl group on the azolium ring.1 The nature of the aromatic ring has been documented to have a profound impact on both reactivity and selectivity across a range of transformations.2 The pentafluorophenyl substituent on the triazolium salt, first introduced by us in 2004,3 exhibits high activity and selectivity across a range of NHC-catalyzed transformations and has become a substituent of choice across a range of reactions, including the intermolecular Stetter,4 redox,5 cascade,6 cycloadditions7 and others.8 Catalyst loadings as low as 0.1 mol% may be used for some reactions (intramolecular Stetter, e.g. 4d) but this is an exception. Given our long history with NHC catalysis and interest in extending the utility of these systems, we expended some effort at identifying decomposition pathways for these carbenes with an eye at the development of the next generation of catalysts. Herein, we disclose our results.

When morpholine-based scaffold pentafluorophenyl triazolium salt 1 was treated with 1 equivalent KOAc as the base in wet MeOH at room temperature for 16 hours (eq. 1), the hydrate 2 and anion-exchanged triazolium salt 3 were observed.9 The hydrate 2 was obtained in 30% isolated yield.10 The hydrate is not particularly stable and slowly decomposed to the salt 3 on standing. We tested the catalytic activity of 3 with aldehyde 5 (eq. 2). Interestingly, the desired product 6 is produced in around 20% conversion in the presence of 20 mol% acetic acid but is not formed in its absence. This suggests that the salt 3 might convert to the corresponding carbene as the catalytic species under acidic conditions.

graphic file with name nihms522306e1.jpg (1)
graphic file with name nihms522306e2.jpg (2)

When the salt 1 was scaled up to 800 mg, the hydrate 2 and a significant amount of 3 were observed. Surprisingly, the interesting inner salt 4 was generated in trace amount.11 The structure of the inner salt 4 was confirmed by X-ray crystallographic analysis (Figure 1). The two fluorinated aryl groups are twisted relative to the triazolium plane. It is clear that one fluoro group on the phenyl ring has been replaced by oxygen.12

Figure 1.

Figure 1

X-ray structure of the triazolium inner salt 4. Thermal ellipsoids are shown at the 50% probability level.

To account for the formation of 4, we propose the mechanism shown below (Scheme 1). The triazolium salt 1 is deprotonated by KOAc to give the free carbene A. Trace water in the reaction results in the formation of triazolium salt 3 with hydroxide as the anion. The hydroxide group can attack the triazolium cation to give the hydrate 2. Additionally, the carbene A nucleophilically attacks the triazolium cation B by SNAr to produce the inner salt D and the neutral compound C. Hydroxide anion present in solution then likely displaces the fluoride on the more activated pentafluorophenyl group to give 4.

Scheme 1.

Scheme 1

Proposed mechanism for the formation of 4.

The SNAr mechanism is also at play in the decomposition of carbenes covalently bound to some substrates. For example, we have found that pentafluorophenyl carbene can react with a Michael acceptor to give a new side product.13 The treatment of Boc-protected oxindole 7 with achiral pentafluorophenyl carbene 8 at room temperature for 48 hours in THF in the presence of potassium carbonate forms the spirocyclic adduct 9 in good yield (75%, eq. 3).14,15 We have shown previously that carbenes can form adducts with electrophiles and carbenes can be released from the adducts.16 In this case, however, the process appears irreversible and carbenes cannot be regenerated. When the reaction time decreased to 16 hours, the yield of the adduct diminished.17

graphic file with name nihms522306e3.jpg (3)

An X-ray quality single crystal of adduct 9 was obtained by slow volatilization of its solution in hexane and dichloromethane. The structure was confirmed by X-ray crystallography (Figure 2). Clearly, the fluoro-substituted phenyl group connects to the spirocenter.

Figure 2.

Figure 2

X-ray structure of spirocyclic oxindole 9. Thermal ellipsoids are shown at the 50% probability level.

The mechanism is proposed as shown below (Scheme 2). The triazolium salt 8 first reacts with potassium carbonate to generate the free carbene E. Then E attacks the double bond on the substrate oxindole to give intermediate F. The enolate anion displaces fluoro group by SNAr to form triazolium salt G. Finally, base induced deprotonation results in sequestration of HF to deliver adduct 9.

Scheme 2.

Scheme 2

Proposed mechanistic pathway

In conclusion, we report two decomposition pathways involving pentafluorophenyl-derived triazolium salt organocatalysts. The structures of these byproducts were confirmed by X-ray crystallographic analysis. Taken together, these results shed light on potential pathways for catalyst decomposition and may lead to the design of new, more efficient catalysts for NHC-mediated transformations.

Supplementary Material

SI

Acknowledgments

We are grateful to NIGMS (GM 72586) for generous support of this research. T.R. thanks Amgen and Roche for support. We thank Donald Gauthier and Greg Hughes (Merck) for a generous gift of aminoindanol.

Footnotes

References

  • 1.(a) Moore JL, Rovis T. Top Curr Chem. 2010;291:77. doi: 10.1007/978-3-642-02815-1_18. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Vora HU, Rovis T. Aldrichimica Acta. 2011;44:3. [PMC free article] [PubMed] [Google Scholar]; (c) Bugaut X, Glorius F. Chem Soc Rev. 2012;41:3511. doi: 10.1039/c2cs15333e. [DOI] [PubMed] [Google Scholar]
  • 2.(a) Rovis T. Chem Lett. 2008;37:2. [Google Scholar]; (b) Mahatthananchai J, Bode JW. Chem Sci. 2012;3:192. doi: 10.1039/C1SC00397F. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Schedler M, Fröhlich R, Daniliuc CG, Glorius F. Eur J Org Chem. 2012:4164. [Google Scholar]
  • 3.Kerr MS, Rovis T. J Am Chem Soc. 2004;126:8876. doi: 10.1021/ja047644h. [DOI] [PubMed] [Google Scholar]
  • 4.(a) Liu Q, Perreault S, Rovis T. J Am Chem Soc. 2008;130:14066. doi: 10.1021/ja805680z. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Liu Q, Rovis T. Org Lett. 2009;11:2856. doi: 10.1021/ol901081a. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) DiRocco DA, Oberg KM, Dalton DM, Rovis T. J Am Chem Soc. 2009;131:10872. doi: 10.1021/ja904375q. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) DiRocco DA, Rovis T. J Am Chem Soc. 2011;133:10402. doi: 10.1021/ja203810b. [DOI] [PMC free article] [PubMed] [Google Scholar]; (e) Sánchez-Larios E, Thai K, Bilodeau F, Gravel M. Org Lett. 2011;13:4942. doi: 10.1021/ol202040b. [DOI] [PubMed] [Google Scholar]
  • 5.For representative examples, see: Reynolds NT, Rovis T. J Am Chem Soc. 2005;127:16406. doi: 10.1021/ja055918a.Vora HU, Rovis T. J Am Chem Soc. 2007;129:13796. doi: 10.1021/ja0764052.Vora HU, Moncecchi JR, Epstein O, Rovis T. J Org Chem. 2008;73:9727. doi: 10.1021/jo8020055.Vora HU, Rovis T. J Am Chem Soc. 2010;132:2860. doi: 10.1021/ja910281s.
  • 6.For representative examples, see: Lathrop SP, Rovis T. J Am Chem Soc. 2009;131:13628. doi: 10.1021/ja905342e.Filloux CM, Lathrop SP, Rovis T. Proc Natl Acad Sci USA. 2010;107:20666. doi: 10.1073/pnas.1002830107.Ozboya KE, Rovis T. Chem Sci. 2011;2:1835. doi: 10.1039/C1SC00175B.Enders D, Grossmann A, Huang H, Raabe G. Eur J Org Chem. 2011:4298.Jacobsen CB, Albrecht L, Udmark J, Jørgensen KA. Org Lett. 2012;14:5526. doi: 10.1021/ol302627u.Liu Y, Nappi M, Escudero-Adán EC, Melchiorre P. Org Lett. 2012;14:1310. doi: 10.1021/ol300192p.Grossmann A, Enders D. Angew Chem Int Ed. 2012;51:314. doi: 10.1002/anie.201105415.
  • 7.Zhao X, DiRocco DA, Rovis T. J Am Chem Soc. 2011;133:12466. doi: 10.1021/ja205714g. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.For representative examples, see: Enders D, Grossmann A, Fronert J, Raabe G. Chem Commun. 2010;46:6282. doi: 10.1039/c0cc02013c.Rong ZQ, Jia MQ, You SL. Org Lett. 2011;13:4080. doi: 10.1021/ol201595f.Jia MQ, You SL. ACS Catal. 2013;3:622.
  • 9.Typical Experimental Procedure for Decomposition of 1: In a 5-mL vial was subsequently added triazolium salt 1 (0.2 mmol), KOAc (0.2 mmol) and MeOH (3 mL). The solution was stirred under argon at 23 °C for 16 h, and then concentrated. The resulting residue was purified by column chromatography on silica gel (eluent: hexanes/ethyl acetate = 1 : 1 to only methanol) to give 2 and 3. The salt 3 can be further purified by trituration with ethyl acetate. Compound 2: yellow solid. 1H NMR (300 MHz, CDCl3) δ 8.26 (d, J = 12.5 Hz, 1H), 7.30 (bs, 4H), 7.00 (bs, 0.5H), 6.31 (bs, 0.5H), 4.74–4.71(m, 1H), 4.63 (t, J = 4.7 Hz, 1H), 4.38–4.21 (m, 2H), 3.26 (dd, J = 16.9, 5.1 Hz, 1H), 3.12 (d, J = 16.9 Hz, 1H). 13C{1H} NMR (75 MHz; CDCl3) δ 163.8, 158.5, 139.3, 128.7, 128.4, 127.4, 125.3, 123.3, 64.3, 57.2, 37.9, 29.3. 19F NMR (282 MHz, CDCl3) δ −142.8 (s, 0.5F), −143.2 (s, 0.5F), −145.8 (d, J = 19.8 Hz, 1F), −152.6 (t, J = 21.4 Hz, 0.5F), −153.4 (t, J = 21.4 Hz, 0.5F), −160.8 (t, J = 19.5 Hz, 1F), −161.5 (s, 1F). LRMS (ES+) m/z calc’d for C18H12F5N3O2 [M]+: 397.09; found 398.10. Compound 3: slightly yellow solid. 1H NMR (400 MHz, CDCl3) δ 13.23 (s, 1H), 7.71 (d, J = 7.5 Hz, 1H), 7.33–7.23 (m, 3H), 6.50 (bs, 1H), 5.05–4.98 (m, 3H), 3.32 (dd, J = 4.2, 17.1 Hz, 1H), 3.19 (d, J = 17.1 Hz, 1H). 13C{1H} NMR (101 MHz, CDCl3) δ 150.6, 148.1 (broad), 139.8, 134.7, 129.7, 128.0, 125.4, 124.2, 77.5, 62.8, 60.3, 37.5. 19F NMR (282 MHz, CDCl3) δ −143.7 (d, J = 18.4 Hz, 2F), −145.7 (t, J = 21.8 Hz, 1F), −157.9–−158.1 (m, 2F). HRMS (ESI) m/z calc’d for C18H11F5N3O [M-OH]+: 380.0817; found: 380.0816.
  • 10.Salt 3 proved difficult to purify to analytically pure material, resulting in significant loss of material. Thus, we do not report an isolated yield here.
  • 11.Compound 4: Orange solid. 1H NMR (300 MHz, CDCl3) δ 7.35 (d, J = 4.1 Hz, 2H), 7.21–7.13 (m, 1H), 6.71 (d, J = 7.8 Hz, 1H), 6.01 (t, J = 3.5 Hz, 1H), 5.17–5.05 (m, 3H), 3.43 (dd, J = 17.0, 4.5 Hz, 1H), 3.34 (d, J = 17.0 Hz, 1H), 1.86–1.62 (bs, 2H from H2O). 13C{1H} NMR (100 MHz, CDCl3) δ 150.7, 139.7, 134.4, 130.3, 128.6, 126.0, 123.8, 98.7, 77.8, 62.9, 62.8, 60.1, 36.9. 19F NMR (376 MHz; CDCl3) δ −142.3–−142.4 (m, 1F), −144.1 (tt, J = 21.6, 4.4 Hz, 1F), −144.2–−144.3 (m, 1F), −144.6–−144.7 (m, 1F), −147.3–−147.4 (m, 1F), −156.5 (td, J = 21.8, 6.8 Hz, 1F), −156.8 (td, J = 21.8, 6.8 Hz, 1F), −163.2 (t, J = 23.0 Hz, 1F), −163.5 (t, J = 23.0 Hz, 1F). HRMS (ESI) m/z calc’d for C24H11F9N3O2 [M+H]+: 544.0708; found 544.0712.
  • 12.This structure is somewhat disordered with what appears to be partial protonation of the phenolic oxygen. There is a corresponding counterion, also disordered, whose identity could not be determined (hydroxide vs fluoride). Both structures (4 and 9) have been submitted to the CCDC: CCDC 935024 and 935025.
  • 13.(a) Enders D, Breuer K, Raabe G, Runsink J, Teles JH, Melder JP, Ebel K, Brode S. Angew Chem Int Ed. 1995;34:1021. [Google Scholar]; (b) Enders D, Breuer K, Kallfass U, Balensiefer T. Synthesis. 2003:1292. [Google Scholar]; (c) Fischer C, Smith SW, Powell DA, Fu GC. J Am Chem Soc. 2006;128:1472. doi: 10.1021/ja058222q. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Yang L, Wang F, Chua PJ, Lv Y, Zhong LJ, Zhong G. Org Lett. 2012;14:2894. doi: 10.1021/ol301175z. [DOI] [PubMed] [Google Scholar]
  • 15.Experimental Procedure for Formation of 9: In a 5-mL vial was subsequently added triazolium salt 8 (0.05 mmol), 7 (0.05 mmol), K2CO3 (0.05 mmol) and THF (4 mL). The vial was capped. The mixture was stirred at 23 °C for 48 h, and then concentrated. The resulting residue was purified by preparative TLC (eluent: hexanes/ethyl acetate = 1 : 1) to give the adduct 9 as a solid. Compound 9: slightly yellow solid. 1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 8.2 Hz, 1H), 7.25 (td, J = 2.4, 8.3 Hz, 1H), 7.07–7.01 (m, 2H), 4.33–4.22 (m, 2H), 3.34 (s, 3H), 2.92–2.88 (m, 2H), 2.54 (p, J = 7.5 Hz, 2H), 1.64 (s, 9H). 13C{1H} NMR (101 MHz, CDCl3) δ 177.2, 164.6, 158.8, 158.7, 149.5, 145.5, 138.7, 134.5, 128.7, 124.7, 123.8, 114.5, 109.9, 84.0, 50.2, 49.3, 28.1, 26.2, 21.2. 19F NMR (282 MHz, CDCl3) δ −134.9 (ddd, J = 5.3, 8.8, 22.5 Hz, 1F), −150.7 (dd, J = 9.0, 20.5 Hz, 1F), −153.87 (dt, J = 5.1, 21.0 Hz, 1F), −160.43 (t, J = 22.0 Hz, 1F). HRMS (ESI) m/z calc’d for C27H23F4N4O5 [M+H]+: 559.1599; found: 559.1603.
  • 16.DiRocco DA, Oberg KM, Rovis T. J Am Chem Soc. 2012;134:6143. doi: 10.1021/ja302031v. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.A catalyst deactivation pathway has been observed for N-phenyl triazolium precursors; see: Hao L, Du Y, Lv H, Chen X, Jiang H, Shao Y, Chi YR. Org Lett. 2012;14:2154. doi: 10.1021/ol300676w.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

SI

RESOURCES